Thu, Oct 30, 2014, 12:13 PM EDT - U.S. Markets close in 3 hrs 47 mins

Recent

% | $
Quotes you view appear here for quick access.

SIGA Technologies, Inc. Message Board

sigakingone 3 posts  |  Last Activity: Oct 17, 2014 4:41 PM Member since: Oct 14, 2014
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    10/22

    by sigakingone Oct 17, 2014 4:37 PM
    sigakingone sigakingone Oct 17, 2014 4:41 PM Flag

    Ostrolenk Faber

    Ostrolenk Faber is a premier intellectual property boutique law firm. Since 1929, we have specialized in domestic and international patent, trademark and copyright law matters. We handle all aspects of IP law from counseling clients to prosecuting their applications to litigating their disputes. Our client base spans from Fortune 500 companies to privately owned businesses to individual inventors. They operate in fields as diverse as consumer electronics, luxury goods, entertainment, pharmaceuticals, and industrial products. With over 75 years of history, we have participated in

  • sigakingone by sigakingone Oct 17, 2014 4:37 PM Flag

    Wednesday, October 22, 2014

    3:00 PM
      14-12623-shl   SIGA Technologies, Inc.    Ch. 11
     
      SECOND DAY HEARING 
     

     
      Doc. #13 (Taxes) Motion to Authorize / Motion of Debtor for Entry of Order Pursuant to 11 U.S.C. §§ 105(a), 363(b), 507(a)(8), and 541 (i) Authorizing, But Not Directing, Debtor to Pay Prepetition Taxes and Assessments and (ii) Authorizing and Directing Financial Institutions to Honor and Process Related Checks and Transfers
     

     
      Doc. #7 (Cash Management) Motion to Authorize / Motion of Debtor for Entry of Order Pursuant to 11 U.S.C. §§ 105(a), 363(b), 363(c), and 364(a) and Fed. R. Bankr. P. 6003 and 6004 (A) Authorizing Debtor to (i) Continue Using Existing Cash Management System, (ii) Honor Certain Prepetition Obligations Related to the Use Thereof and (iii) Maintain Existing Bank Accounts and Business Forms; and (B) Scheduling a Final Hearing
     

     
      Doc. #8 (Wages) Motion to Authorize / Motion of Debtor for Entry of Order Pursuant to 11 U.S.C. §§ 105(a) and 363(b) Authorizing (I) Payment of Prepetition Wages, Salaries, and Other Compensation and Benefits, (II) Maintenance of Employee Benefits Programs and Payment of Related Administrative Obligations, and (III) Applicable Banks and Other Financial Institutions to Receive, Process, Honor, and Pay All Checks Presented for Payment and to Honor All Fund Transfer Requests
     

     
      Doc. #9 (Critical Vendor) Motion to Authorize / Motion of Debtor for Entry of Order Pursuant to 11 U.S.C. §§ 105 and 363(b) (i) Authorizing, But Not Directing, Debtor to Pay Prepetition Obligations of Critical Vendors, (ii) Authorizing and Directing Financial Institutions to Honor and Process Related Checks and Transfers, and (iii) Scheduling Final Hearing
     

     
      Doc. #12 (Insurance) Motion to Authorize / Motion of Debtor for Entry of Order Pursuant to 11 U.S.C. §§ 105(a), 362(d), 363(b), and 503(b) (i) Authorizing, But Not Directing, Debtor to (A) Continue Its Insurance Programs and (B) Pay All Insurance Obligations, (ii) Modifying the Automatic Stay with Respect to Workers Compensation Claims, and (iii) Authorizing and Directing Financial Institutions to Honor and Process Related Checks and Transfers
     

     
      Doc. #14 (Utilities) Motion to Authorize / Motion of Debtor for Entry of Order Pursuant to 11 U.S.C. §§ 105(a) and 366 (I) Approving Debtors Proposed Form of Adequate Assurance of Payment to Utilities, (II) Establishing Procedures for Resolving Objections by Utility Companies, and (III) Prohibiting Utilities from Altering, Refusing, or Discontinuing Service
     

     
      Doc. #50 Motion to Approve / Motion of Debtor for Entry of Order Pursuant to 11 U.S.C. 105(a) and 331 Establishing Procedures for Interim Compensation and Reimbursement of Expenses of Professionals
     

     
      Doc. #51 Motion to Authorize / Motion of Debtor for Entry of Order Pursuant to 11 U.S.C. 105(a) and 1107(a) Authorizing, But Not Directing, Debtor to Pay Reimbursable Prepetition Obligations to Certain Service Providers
     

     
      Doc. #54 Application To Employ Ostrolenk Faber LLP as Intellectual Property Counsel for the Debtor / Application of Debtor Pursuant to 11 U.S.C. § 327(e) and Fed. R. Bankr. P. 2014(a) for Authority to Employ and Retain Ostrolenk Faber LLP as Intellectual Property Counsel for the Debtor Nunc Pro Tunc to the Commencement Date
     

     
      Doc. #53 Motion To Authorize / Motion of Debtor for Entry of Order Pursuant to 11 U.S.C. 105(a), 327, 328, and 330 for Authorization to Employ Certain Professionals Used in the Ordinary Course of Business Nunc Pro Tunc to the Commencement Date
     

     
      Doc. #49 Application To Employ Weil, Gotshal & Manges LLP as Attorneys for the Debtor / Application of Debtor Pursuant to 11 U.S.C. § 327(a) and Fed. R. Bankr. P. 2014(a) for Authority to Employ and Retain Weil, Gotshal & Manges LLP as Attorneys for the Debtor Nunc Pro Tunc to the Commencement Date
     

     
      Doc. #52 Application To Employ Prime Clerk LLC as Claims and Noticing Agent / Application of Debtor Pursuant to 28 U.S.C § 156(c), 11 U.S.C. § 105(a), and S.D.N.Y. LBR 5075-1 for Authority to Appoint Prime Clerk LLC as Claims and Noticing Agent
     

     
      Cash Collateral
     

     
      Doc. #10 Motion to Authorize / Motion of Debtor for Entry of Order Pursuant to 11 U.S.C. §§ 105 and 546(c) Establishing and Implementing Exclusive and Global Procedures for Treatment of Reclamation Claims
    Withdrawn
     

    Sentiment: Strong Buy

  • sigakingone by sigakingone Oct 14, 2014 11:41 PM Flag

    Novel broad-spectrum antimicrobials are a critical component of a strategy for combating antibiotic-resistant pathogens. In this study, we explored the activity of the broad-spectrum antiviral compound ST-669 for activity against different intracellular bacteria and began a characterization of its mechanism of antimicrobial action. ST-669 inhibits the growth of three different species of chlamydia and the intracellular bacterium Coxiella burnetii in Vero and HeLa cells but not in McCoy (murine) cells. The antichlamydial and anti-C. burnetii activity spectrum was consistent with those observed for tested viruses, suggesting a common mechanism of action. Cycloheximide treatment in the presence of ST-669 abrogated the inhibitory effect, demonstrating that eukaryotic protein synthesis is required for tested activity. Immunofluorescence microscopy demonstrated that different chlamydiae grow atypically in the presence of ST-669, in a manner that suggests the compound affects inclusion formation and organization. Microscopic analysis of cells treated with a fluorescent derivative of ST-669 demonstrated that the compound localized to host cell lipid droplets but not to other organelles or the host cytosol. These results demonstrate that ST-669 affects intracellular growth in a host-cell-dependent manner and interrupts proper development of chlamydial inclusions, possibly through a lipid droplet-dependent process.
    Zip4pip

    Sentiment: Strong Buy

SIGA
1.35-0.02(-1.46%)11:56 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.